The United States of America, as Represented by the Secretary, Department of Health and Human Services

US Government as Represented by the Secretary of the Army

Malliga R Iyer

Kenner C Rice

George Kunos

Resat Cinar

Carl R Alving

Arthur E Jacobson

William A Gahl

Gary R Matyas

Alexander V Mayorov

Fuying Li

Bernadette R Gochuico

May Christine Vergara Malicdan

Kejun Cheng

A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CBreceptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.

Cannabinoid receptor mediating compounds

A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CBreceptor mediating scaffold and (ii) a second therapeutic scaffold.

Cannabinoid receptor mediating iminopyrazole compounds

A compound, or a pharmaceutically acceptable salt or ester thereof, having a structure of: wherein X and Y are each independently selected from optionally-substituted aryl, optionally-substituted heteroaryl, optionally-substituted cycloalkyl, optionally-substituted heterocycloalkyl, or optionally-substituted alkyl;

Pyrazole derivatives and their use as cannabinoid receptor mediators

In this application is described a composition and method for inducing in a subject anti-hapten antibodies without inducing antibodies to the carrier protein. Kits for designing and making compositions with desired haptens are also described.

Induction of highly specific antibodies to a hapten but not to a carrier peptide by immunization

Growing community of inventors

Germantown, MD, United States of America

Malliga R Iyer